The medical community is buzzing by retatrutide, a innovative dual GIP and GLP-1 agonist that’s showing significant results in preliminary research. This compound works by imitating natural hormones to impact appetite and promote feelings of fullness , ultimately leading noticeable weight reduction . While currently under investigation and not ye